Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-31

Clinical Trial Update: A Study Evaluating the Overall Pain Relief and Safety of Intravenous (IV) CR845 in Patients Undergoing Abdominal Surgery [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for IV CR845 in patients undergoing abdominal surgery showing phase 2/3 data on pain relief and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CR845 (difelikefalin)

Snippet

Sponsor: Cara Therapeutics, Inc. | Conditions: Post Abdominal Surgery Pain | Phase 2, Phase 3 | Status: COMPLETED